Jim Simons’s Ensysce Biosciences ENSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.5K Buy
+30,160
New +$11.2K ﹤0.01% 3142
2025
Q4
– Sell
-15,574
Closed -$36.9K – 3377
2025
Q3
$36.9K Buy
+15,574
New +$33.5K ﹤0.01% 3379
2024
Q4
– Sell
-1,493
Closed -$5.38K – 3659
2024
Q3
$5.38K Buy
+1,493
New +$9.06K ﹤0.01% 3476
2024
Q2
– Sell
-704
Closed -$8K – 3604
2024
Q1
$8K Sell
704
-26
-4% -$413 ﹤0.01% 3634
2023
Q4
$12K Buy
+730
New +$11.8K ﹤0.01% 3625
2022
Q3
– Sell
-99
Closed -$309K – 4101
2022
Q2
$309K Buy
99
+19
+24% +$53.2K ﹤0.01% 3440
2022
Q1
$328K Buy
+80
New +$529K ﹤0.01% 3432

Other funds holding ENSC

Jim Simons's ENSC Position: Q3 2026 in Review

Jim Simons opened a new position in Ensysce Biosciences (ENSC) in Q3 2026: 30,160 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #3142 among its holdings. This is a return to the name: Jim Simons previously reported a position in ENSC as recently as Q3 2025.

Jim Simons first reported a position in ENSC in Q1 2022 and has held it in 7 quarters since. The position peaked at $328K in Q1 2022. 12 funds tracked by Wall St. Rank hold ENSC as of Q3 2026.

  • Jim Simons held 30,160 shares of Ensysce Biosciences worth $12.5K as of Q3 2026.
  • Ensysce Biosciences was a new Jim Simons position in Q3 2026.
  • Ensysce Biosciences made up ﹤0.01% of Jim Simons's portfolio in Q3 2026, its #3142 holding.
  • Jim Simons first reported a position in Ensysce Biosciences in Q1 2022 and has held it in 7 quarters since.
  • Jim Simons's Ensysce Biosciences position peaked at $328K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.